SDC1 and plasma cell myeloma: Sun Sun C C Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma Oncotarget Oncotarget 2019 2019 10 10 24 24 2369 2369 2383 2383 10.18632/oncotarget.26792 10.18632/oncotarget.26792 31040928 31040928